The Journal of Organic Chemistry
Brief Communication
pad of Celite, and concentrated in vacuo. The crude product was
added. The reactant mixture was heated in a 90 °C oil bath until
metalloamination was complete (90% by H NMR, p-xylene as
internal standard). The volatiles were removed in vacuo, and THF (0.5
1
purfied by bulb to bulb distillation (75−80 °C, 0.5 Torr) to afford 0.52
1
g (85%) of the title compound. H NMR (500 MHz, CDCl ): δ 7.42
3
(
6
2
d, J = 7.2 Hz, 2H), 7.26 (t, J = 7.5 Hz, 2H), 7.17 (t, J = 7.2 Hz, 1H),
mL) was introduced to the J. Young tube in an argon-filled drybox
14
.52 (d, J = 15.7 Hz, 1H), 6.43 (dt, J = 15.7, 7.5 Hz, 1H), 2.66 (s, 2H),
followed by the addition of a solution of CuCN·2LiCl in THF (150
μL, 1.0 M, 0.15 mmol). After 5 min, methallyl chloride (10.9 mg, 0.12
mmol)] was added, and the reactant mixture was kept at 23 °C for 2 h
.36 (s, 6H), 2.29 (d, J = 7.5 Hz, 2H), 1.78 (s, 1H), 1.07 (s, 6H). 13
C
NMR (126 MHz, CDCl ): δ 138.6, 132.8, 128.9, 128.0, 127.3, 126.6,
5
3
1
9.2, 47.9, 44.3, 35.3, 26.2. IR (film): 3197, 3025, 2949, 2835, 2764,
(or until the reaction was complete 95% H NMR). The Teflon screw
1
494, 1474, 1448, 966, 692 HRMS (ESI): calcd for C H N [M +
cap was removed, the reactant mixture was transferred to a 10 mL test
tube and diluted with diethyl ether (2.0 mL), and an aqueous solution
of NH Cl (satd) and NH /H O (1:1 v/v, 2 mL) was subsequently
added. The resulting suspension was vigorously stirred for 10 min until
the aqueous layer developed a deep blue color. The organic layer was
15
24
2
+
H] 233.2018, found 233.2045.
(
E)-2-(5-(2-Chlorophenyl)-2,2-dimethylpent-4-en-1-yl)-1,1-dime-
4
3
2
thylhydrazine (5a ). The title compound was synthesized by the
general reduction procedure of 5a utilizing hydrazone 3aCl (0.794 g,
3
Cl
.00 mmol) and NaBH CN (0.375 g, 6.00 mmol) to yield (E)-2-(5-(2-
removed and washed with a second portion of NH Cl (satd) and
3
4
chlorophenyl)-2,2-dimethylpent-4-en-1-yl)-1,1-dimethylhydrazine
NH /H O (1:1 v/v, 2 mL) followed by brine (2 mL) and dried with
3
2
1
(
0.640 g, 80%) as a clear oil. H NMR (500 MHz, CDCl ): δ 7.41 (td,
MgSO . The ether solution was then transferred to a 10 mL round-
3
4
J = 7.7, 1.8 Hz, 1H), 7.13 (tdd, J = 7.2, 5.1, 1.8 Hz, 1H), 7.04 (td, J =
.5, 1.3 Hz, 1H), 6.98 (ddd, J = 10.9, 8.1, 1.3 Hz, 1H), 6.52 (d, J = 15.9
Hz, 1H), 6.31 (dt, J = 15.6, 7.6 Hz, 1H), 2.58 (s, 2H), 2.45−2.38 (m,
bottomed flask equipped with a magnetic stirring bar and a N inlet
2
7
and cooled to 0 °C. Trifluoroacetic acid (13.7 mg, 0.12 mmol) was
added dropwise via a gastight syringe, and the reactant mixture was
allowed to stir for 1 h. The volatiles were removed in vacuo, and the
resultant viscous oil was triturated with pentane (3 × 1 mL) to afford
the trifluoroacetate salts 6.
13
6H), 2.16 (dd, J = 7.6, 1.3 Hz, 2H), 1.92 (s, 1H), 0.92 (s, 6H).
C
NMR (126 MHz, CDCl ): δ 130.5, 128.0, 127.9, 127.1, 124.3, 123.9,
3
1
1
2
15.7, 115.5, 58.7, 47.8, 44.2, 34.6, 25.8. IR (film): 2950, 2832, 1489,
−1
+
223, 979, 741 cm . HRMS (ESI): calcd for C H ClN [M + H]
N,N,4,4-Tetramethyl-2-(3-methyl-1-phenylbut-3-en-1-yl)-
15
23
2
66.1550, found 266.1562.
pyrrolidin-1-amine (6a). The title compound was isolated as a clear
1
(
E)-2-(5-(2-Fluorophenyl)-2,2-dimethylpent-4-en-1-yl)-1,1-dime-
oil (free base) (22.6 mg, 79%). H NMR (500 MHz, CDCl
3
): δ =
thylhydrazine (5a ). The title compound was synthesized by the
7.27−7.22 (m, 2H), 7.21−7.17 (m, 2H), 7.17−7.13 (m, 1H), 4.70−
4.61 (m, 1.5H), 3.39 (tt, J = 8.0, 3.6, 1H), 2.97 (td, J = 8.2, 4.3, 0.8H),
2.67 (d, J = 14.5, 0.3H), 2.61 (d, J = 8.0, 0.3H), 2.52 (dd, J = 14.3, 7.8,
0.8H), 2.44−2.40 (m, 1.5H), 2.37 (s, 6H), 2.34−2.30 (m, 1H), 1.69 (s,
2.2H), 1.65 (s, 0.8H), 1.28 (dd, J = 12.5, 8.9, 1H), 1.19−1.13 (m, 1H),
F
general reduction procedure of 5a utilizing hydrazone 3a (0.751 g,
F
3
.00 mmol) and NaBH CN (0.375 g, 6.00 mmol) to yield (E)-2-(5-(2-
3
fluorophenyl)-2,2-dimethylpent-4-en-1-yl)-1,1-dimethylhydrazine
1
(
0.668 g, 89%) as a clear oil. H NMR (500 MHz, CDCl ): δ 7.41 (td,
3
1
3
J = 7.7, 1.8 Hz, 1H), 7.13 (tdd, J = 7.2, 5.1, 1.8 Hz, 1H), 7.04 (td, J =
.5, 1.3 Hz, 1H), 6.98 (ddd, J = 10.9, 8.1, 1.3 Hz, 1H), 6.52 (d, J = 15.9
Hz, 1H), 6.31 (dt, J = 15.6, 7.6 Hz, 1H), 2.58 (s, 2H), 2.45−2.38 (m,
1.08 (s, 1H), 0.93 (s, 1H), 0.92 (s, 2H), 0.52 (s, 2H). C NMR (126
7
MHz, CDCl ): δ = 144.6, 129.9, 128.6, 127.9, 127.0, 125.7, 125.6,
3
111.5, 65.6, 63.4, 53.6, 52.8, 43.3, 43.2, 40.5, 39.8, 39.6, 38.7, 38.3,
1
3
6
H), 2.16 (dd, J = 7.6, 1.3 Hz, 2H), 1.92 (s, 1H), 0.92 (s, 6H).
C
34.9, 33.5, 30.6, 29.3, 29.2, 29.0, 22.7, 22.3. IR (film): 2938, 2863,
1
−1
NMR (126 MHz, CDCl ): δ 159.9 (d, J
= 248.1), 130.5, 128.0,
2812, 1452, 1181, 700, cm . HRMS (ESI): calcd for C H N [M +
3
C−F
19 31
2
+
1
27.9, 127.1, 124.3, 123.9, 115.7, 115.5, 58.7, 47.8, 44.2, 34.6, 25.8. IR
H] 287.2487, found 287.2566.
−
1
(film): 2952, 2837, 1486, 1455, 1229, 970, 753 cm . HRMS (ESI):
2-(1-(2-Chlorophenyl)-3-methylbut-3-en-1-yl)-N,N,4,4-tetra-
+
calcd for C H FN [M + H] 251.1924, found 251.1912.
methylpyrrolidin-1-amine (6aCl). The title compound was isolated
15
23
2
1
(E)-2-(5-Cyclopropyl-2,2-dimethylpent-4-en-1-yl)-1,1-dimethylhy-
as a mixture of diastereomers (1:10) (free base) (23.1 mg, 72%). H
drazine (5b). The title compound was synthesized by the general
reduction procedure of hydrazine 5a utilizing hydrazone 3b (0.988 g,
NMR (500 MHz, CDCl ): δ 7.27 (ddd, J = 13.7, 8.2, 1.7 Hz, 2H), 7.15
3
(td, J = 7.5, 1.4 Hz, 1H), 7.09−7.00 (m, 1H), 4.49 (s, 1H), 4.39 (s,
1H), 3.59 (ddd, J = 11.7, 7.5, 4.0 Hz, 1H), 3.02 (dt, J = 14.1, 5.4 Hz,
2H), 2.58 (d, J = 8.5 Hz, 1H), 2.52 (d, J = 8.4 Hz, 1H), 2.40 (s, 1H),
2.31 (s, 6H), 1.66 (s, 3H), 1.30−1.26 (m, 1H), 1.25−1.22 (m, 1H),
5
.00 mmol) and NaBH CN (0.628 g, 10.0 mmol) to yield (E)-2-(5-
3
cyclopropyl-2,2-dimethylpent-4-en-1-yl)-1,1-dimethylhydrazine (0.746
1
g, 76%) as a clear liquid. H NMR (500 MHz, CDCl ): δ 5.45 (dt, J =
3
1.07 (s, 3H), 0.93 (s, 3H). 13C NMR (126 MHz, CDCl ): δ 144.8,
15.1, 7.5 Hz, 1H), 4.92 (dd, J = 15.1, 8.4 Hz, 1H), 2.48 (s, 2H), 2.36
3
(
0
s, 6H), 1.84 (s, 2H), 1.30 (qt, J = 8.4, 4.8 Hz, 1H), 0.82 (s, 6H),
.65−0.54 (m, 2H), 0.26 (dt, J = 6.3, 4.2 Hz, 2H). C NMR (126
142.1, 134.7, 129.6, 129.16 126.5, 126.1, 111.2, 64.9, 53.2, 42.9, 40.8,
13
39.8, 34.5, 29.3, 28.7, 22.5. IR (film): 2952, 2865, 2844, 1472, 1441,
−1
H29ClN
[M + H]+
2
MHz, CDCl ): δ 136.2, 124.3, 58.5, 47.7, 43.3, 34.0, 25.6, 24.6, 13.5,
6
6
1025, 884, 750 cm . HRMS (ESI): calcd for C19
321.2098, found 321.2101.
3
.3. IR (film): 3017, 2921, 2722, 1423, 1402, 1319, 1021, 953, 818,
−1
+
35, 562 cm . HRMS (ESI): calcd for C H N [M + H] 197.2018,
2-(1-(2-Fluorophenyl)-3-methylbut-3-en-1-yl)-4,4-N,N-tetra-
methylpyrrolidin-1-amine (6a ). The title compound was isolated
as a clear oil (free base) (23.7 mg, 78%). H NMR (500 MHz,
CDCl ): δ 7.17 (td, J = 7.5, 1.8 Hz, 1H), 7.11 (tdd, J = 7.3, 5.1, 1.8 Hz,
12
24
2
found 197.2033.
F
1
(
Z)-2-(6-(Benzyloxy)-2,2-dimethylhex-4-en-1-yl)-1,1-dimethylhy-
drazine (5c). The title compound was synthesized by the general
reduction method of hydrazine 5a utilizing hydrazone 3c (1.00 g, 3.64
mmol) and NaBH CN (0.458 g, 7.29 mmol) to yield (Z)-2-(6-
3
1H), 7.01 (td, J = 7.5, 1.3 Hz, 1H), 6.94 (ddd, J = 10.9, 8.1, 1.3 Hz,
1H), 4.55 (d, J = 10.8 Hz, 2H), 3.50 (dd, J = 10.6, 5.7 Hz, 1H), 3.10−
2.98 (m, 1H), 2.76 (dd, J = 14.4, 5.8 Hz, 1H), 2.52−2.38 (m, 3H),
2.39−2.29 (m, 6H), 1.65 (s, 3H), 1.34 (dd, J = 12.8, 8.7 Hz, 1H),
3
(
benzyloxy)-2,2-dimethylhex-4-en-1-yl)-1,1-dimethylhydrazine (0.916
1
g, 91%) as a clear oil. H NMR (500 MHz, DMSO): δ 7.33 (q, J = 3.9,
2
13
.9 Hz, 4H), 7.26 (ddd, J = 7.3, 4.9, 2.3 Hz, 1H), 5.72−5.60 (m, 2H),
.50 (s, 2H), 4.07 (d, J = 5.8 Hz, 2H), 2.51 (s, 2H), 2.38 (s, 6H), 1.99
1.27−1.19 (m, 1H), 0.93 (s, 3H), 0.77 (s, 3H). C NMR (126 MHz,
CDCl ): δ 161.5 (d, 1JC-F = 244.1), 144.6, 131.2, 129.9, 127.1, 123.1,
4
(
3
d, J = 7.0 Hz, 2H), 1.86 (s, 1H), 0.86 (s, 6H). 13C NMR (126 MHz,
115.1, 115.0, 111.3, 64.0, 53.0, 41.1, 40.4, 39.8, 34.1, 29.2, 28.9, 22.2.
CDCl ): δ 138.4, 130.1, 128.3, 127.9, 127.8, 127.5, 127.5, 72.2, 65.9,
5
1
IR (film): 3072, 2950, 2865, 2770, 1648, 1582, 1489, 1453, 1222, 886,
3
−1
+
8.6, 47.7, 37.7, 34.4, 25.6. IR (film): 2956, 2926, 2853, 1468, 1444,
754 cm . HRMS (ESI): calcd for C19
found 305.2357.
H30FN [M + H] 305.2394,
2
−1
098, 1072, 1026, 1010, 735, 698 cm . HRMS (ESI): calcd for
+
C H N O [M + H] 277.2281, found 277.2276.
N,N,4,4-Tetramethyl-2-vinylpyrrolidin-1-amine (9). The title
17
28
2
1
Synthesis of Cyclic Hydrazines. General Procedure for
compound was isolated as a clear oil (TFA salt) 25.4 mg (90%). H
CuCN-Mediated Allylation of Metalloamination Intermediates.
NMR (500 MHz, CDCl ): δ 5.84 (ddd, J = 17.2, 10.2, 8.4 Hz, 1H),
3
In an argon-filled glovebox, ZnEt in p-xylene (50 μL, 2.0 M, 0.10
5.36−5.22 (m, 2H), 3.81 (q, J = 8.3 Hz, 1H), 3.16 (d, J = 8.8 Hz, 1H),
2
mmol) and toluene or (trifluoromethyl)benzene (0.5 mL) were
introduced into a J. Young NMR tube equipped with a Teflon screw
cap, and hydrazinoalkene (5a−c) (0.10 mmol) was subsequently
2.95 (s, 6H), 2.81 (d, J = 8.8 Hz, 1H), 1.92 (dd, J = 13.1, 8.0 Hz, 1H),
1
3
1.62 (dd, J = 13.1, 8.5 Hz, 1H), 1.16 (s, 3H), 1.13 (s, 3H). C NMR
(126 MHz, CDCl ): δ 136.2, 119.8, 64.9, 60.9, 45.0, 42.0, 35.0, 29.1,
3
D
J. Org. Chem. XXXX, XXX, XXX−XXX